Cathie Wood’s IceCure Medical ICCM Stock Holding History

Cathie Wood’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,496	Closed	-$1.4M	–	366
2021 Q4	$1.4M	Buy	15,496 +5,056	+48%	+$845K	﹤0.01%	251
2021 Q3	$2.73M	Buy	+10,440	New	+$3.09M	0.01%	240

Other funds holding ICCM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCM

Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Cathie Wood's ICCM Position: Q1 2022 in Review

Cathie Wood sold out of IceCure Medical (ICCM) in Q1 2022, closing a stake of 15,496 shares — an estimated $1.4M sold.

Cathie Wood first reported a position in ICCM in Q3 2021 and held it in 2 quarters. The position peaked at $2.73M in Q3 2021. 9 funds tracked by Wall St. Rank hold ICCM as of Q1 2022.

Cathie Wood reported no remaining IceCure Medical position as of Q1 2022 after selling out during the quarter.
Cathie Wood sold 15,496 IceCure Medical shares in Q1 2022, an estimated $1.4M.
Cathie Wood first reported a position in IceCure Medical in Q3 2021 and held it in 2 quarters.
Cathie Wood's IceCure Medical position peaked at $2.73M in Q3 2021.
9 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2022.

Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.